Active Ingredient: DESVENLAFAXINE SUCCINATE
Proprietary Name: DESVENLAFAXINE SUCCINATE
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: EQ 25MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A204082
Product Number: 002
Approval Date: Aug 28, 2017
Applicant Holder Full Name: HIKMA PHARMACEUTICALS USA INC
Marketing Status:
Prescription
Patent and Exclusivity Information
